Industry: Omics-Based Biomarkers
Estimated Revenue: $8.9Mper year
Number Of Exists: 116
Headquarters: US
Investor Type: Healthcare-focused Hedge Funds
Employee Number: 11-50
Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity
Founded Date: 1999-01-01